Tipsheet
What matters at India’s listed companies
Earnings · Pharmaceuticals · Micro cap

Denis Chem Lab posts ₹8.41 cr profit, declares ₹2.50 dividend

Annual profit rose 4% but the real news is the 3.4% dividend yield from a ₹101 crore market-cap company.


Mkt cap₹100 cr
P/E11.92×
ROE9.49%
Debt / eq.0.01
₹2.50 per share Final dividend yielding ~3.4% on a ₹101 crore market cap

What's new

  • FY26 net profit of ₹8.41 crore on ₹181.72 crore revenue, up 4% and 5% respectively.
  • Board recommends final dividend of ₹2.50 per share, yielding ~3.4%.
  • New secretarial and cost auditors appointed after a resignation.

Why this matters

For a nano-cap, a 3.4% dividend yield is the headline event. The underlying earnings growth of 4% is flat, but the board chose to signal confidence with a payout that stands out for a company of this size.

What we're watching

  • Whether the Q4 profit decline becomes a trend in FY27.
  • If the dividend policy continues at this yield level.
  • The impact of auditor changes on governance perception.

The full read

Denis Chem Lab's full-year numbers are steady: ₹8.41 crore net profit, 4% higher than last year, on ₹181.72 crore revenue. The payout is the story. The board has recommended a final dividend of ₹2.50 per share. At a market capitalisation of ₹101 crore, that yields 3.4%. For a nano-cap, that's a meaningful return to shareholders, and the board's chosen signal. The backdrop is a 43% year-on-year drop in Q4 net profit, a detail the annual summary softens but the quarterly figures do not. The company also replaced its secretarial auditor after a resignation and locked in a cost auditor for the coming year. The open question is whether the dividend sets a floor or a ceiling for future payouts, and how that Q4 slip translates into FY27.

Questions answered

How did Denis Chem Lab's profitability change this year?
Net profit grew 4% year-on-year to ₹8.41 crore, while revenue increased 5% to ₹181.72 crore. However, Q4 net profit dropped 43% from the prior year.
What is the significance of the dividend recommendation?
The ₹2.50 per share dividend yields approximately 3.4% on the company's ₹101 crore market capitalization. For a nano-cap, this is a meaningful return for shareholders.
Why were new auditors appointed?
The company appointed M/s. Kashyap R. Mehta & Partners as secretarial auditors to fill a casual vacancy after a resignation. M/s. Kiran J. Mehta & Co. were named cost auditors for FY27.
What does the 43% Q4 profit drop mean for the annual result?
The sharp quarterly decline in Q4 net profit was absorbed into the full-year number, which still managed a 4% gain. It raises a question about the trajectory of earnings momentum heading into FY27.
Mentioned: ₹8.41 crore net profit · ₹2.50 per share dividend · Q4 net profit 43% drop
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Denis Chem Lab Ltd.

Pharmaceuticals
₹104 cr
P/E 12.35×

Latest quarter · Mar 2026

Sales₹47 cr
Net profit₹0 cr
Op. margin+5.4%
EPS₹0.29

Strength & growth

Debt / equity0.01×
Current ratio2.70×
Sales CAGR+6.2%
EPS CAGR+16.7%